Cardiac Biotech Solutions Inc.
Cardiac Biotech Solutions Inc. financial statements
Cardiac Biotech Solutions Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.
FY2026
| Revenue | USD 152.73K | EODHD |
| Net income | −USD 895.97K | EODHD |
| Cash and equivalents | USD 3.86K | EODHD |
| Total debt | USD 537.5K | EODHD |
Cardiac Biotech Solutions Inc. financials on 6ix · Cardiac Biotech Solutions Inc. on 6ix